Is it time to re-classify Crohn's disease?

Farmer, 1975, Clinical patterns in Crohn's disease: a statistical study of 615 cases, Gastroenterology, 68, 627, 10.1016/S0016-5085(75)80270-8 Farmer, 1985, Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis, Gastroenterology, 88, 1818, 10.1016/0016-5085(85)90006-X Griffiths, 1991, Factors influencing postoperative recurrence of Crohn's disease in childhood, Gut, 32, 491, 10.1136/gut.32.5.491 Greenstein, 1988, Peforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms, Gut, 29, 588, 10.1136/gut.29.5.588 Gilberts, 1994, Molecular evidence for two forms of Crohn disease, Proc Natl Acad Sci USA, 91, 12721, 10.1073/pnas.91.26.12721 Aeberhard, 1996, Surgical recurrence of perforating and nonperforating Crohn's disease. A study of 101 surgically treated Patients, Dis Colon Rectum, 39, 80, 10.1007/BF02048274 Steinhart, 1998, Reliability of a Crohn's disease clinical classification scheme based on disease behavior, Inflamm Bowel Dis, 4, 228, 10.1002/ibd.3780040307 Gasche, 2000, A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998, Inflamm Bowel Dis, 6, 8, 10.1002/ibd.3780060103 Cosnes, 2002, Long-term evolution of disease behavior of Crohn's disease, Inflamm Bowel Dis, 8, 244, 10.1097/00054725-200207000-00002 Veloso, 2001, Clinical outcome of Crohn's disease: analysis according to the Vienna classification and clinical activity, Inflamm Bowel Dis, 7, 306, 10.1097/00054725-200111000-00005 Freeman, 2001, Application of the Vienna Classification for Crohn's disease to a single clinician database of 877 patients, Can J Gastroenterol, 15, 89, 10.1155/2001/426968 Louis, 2001, Behavior of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease, Gut, 49, 777, 10.1136/gut.49.6.777 Louis, 2003, Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype, Gut, 52, 552, 10.1136/gut.52.4.552 Reinshagen, 1996, HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany, Gut, 38, 538, 10.1136/gut.38.4.538 Danze, 1996, Association of HLA class II genes with susceptibility to Crohn's disease, Gut, 39, 69, 10.1136/gut.39.1.69 Trachtenberg, 2000, HLA class II haplotype associations with IBD, Hum Immunol, 61, 326, 10.1016/S0198-8859(99)00134-2 Stokkers, 1999, HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis, Gut, 45, 395, 10.1136/gut.45.3.395 Hampe, 2002, Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study, Lancet, 359, 1661, 10.1016/S0140-6736(02)08590-2 Helio, 2003, CARD15/NOD2 gene variants are associated with familiarly occurring and complicated forms of Crohn's disease, Gut, 52, 558, 10.1136/gut.52.4.558 Ahmad, 2002, The molecular classification of the clinical manifestations of Crohn's disease, Gastroenterology, 122, 854, 10.1053/gast.2002.32413 Hugot, 2001, Association of NOD2 with susceptibility of Crohn's disease, Nature, 441, 599, 10.1038/35079107 Allcock, 2001, The central MHC gene BAT1, may encode a protein that down-regulates cytokine production genes, Cells, 6, 487, 10.1046/j.1365-2443.2001.00435.x Abreu, 2002, Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease, Gastroenterology, 123, 679, 10.1053/gast.2002.35393 Radlmayr, 2002, The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease, Gastroenterology, 122, 2091, 10.1053/gast.2002.34020 Murillo, 2002, CARD15 gene and the classification of Crohn's disease, Immunogenetics, 54, 59, 10.1007/s00251-002-0440-1 Markowitz, 2000, A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease, Gastroenterology, 119, 895, 10.1053/gast.2000.18144 Caesar, 1997, Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group, Hepatogastroenterology, 44, 445 Sachar, 1992, Proposed Classification of Patient Subgroups in Crohn's Disease, Gastroenterol Int, 5, 141